CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones
Data from Single Ascending Dose (SAD) portion of Phase 1 study of CMP-CPS-001 for the treatment of urea cycle disorders (UCDs) demonstrates favorable safety resultsCompleted dosing in the first two ...
Hosted on MSN1d
Aussie Rare Earths snags first $750K from gov't for 2026 demo plant
Australian Rare Earths (ASX:AR3) is now sitting on $750,000 after receiving the first of a larger $5 million payment from ...